Php32 - Impact of Manufacturer Competition on Prescription Drug Price Inflation in the United States

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.928
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Drug Importation Into the United States: Impact on Canada

CMAJ
Medicine
2017English

377 the Prescription Drug Epidemic in the United States – Efforts to Improve Prescribing

Injury Prevention
EnvironmentalPublic HealthOccupational Health
2016English

Inflation Targeting in the United States?

2003English

Monetary Union, Price Level Convergence, and Inflation: How Close Is Europe to the United States?

SSRN Electronic Journal
2002English

Php30 - The Contribution of New Product Entry vs Existing Product Inflation in the Rising Costs of Prescription Drugs in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Influence of Regulation on Competition in the United States Banking Industry

1977English

The Optimal Emission Reduction Rate and Price With Carbon Quota and Manufacturer Competition

2018English

Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy